In situ hybridization for the detection of telomerase RNA in the progression from Barrett's esophagus to esophageal adenocarcinoma

Cancer

Volumn 83, Issue 4, 1998, Pages 652-659

  Morales, Carmela P ^a   Lee, Edward L ^b   Shay, Jerry W ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Veterans Affairs North Texas Health Care System   (United States)

Author keywords

Barrett's esophagus; Esophageal adenocarcinoma; In situ hybridization; Telomerase RNA

Indexed keywords

CELL MARKER; TELOMERASE;

ANIMAL TISSUE; ARTICLE; CANCER GRADING; ENZYME ACTIVITY; ESOPHAGUS CARCINOMA; GENE MUTATION; HUMAN; IN SITU HYBRIDIZATION; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RNA ANALYSIS;

ADENOCARCINOMA; BARRETT ESOPHAGUS; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; HUMANS; IN SITU HYBRIDIZATION; MALE; PRECANCEROUS CONDITIONS; RNA, NEOPLASM; TELOMERASE;

EID: 0031865011     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0142(19980815)83:4<652::AID-CNCR4>3.0.CO;2-M     Document Type: Article

References (28)

1. Blot WJ, Devesa SS, Kneller RW, Fraumeni JF Jr. Rising incidence of adenocarcinoma of the esophagus and gastric cardia. JAMA 1991;265:1287-9.
2. Haggitt RC. Adenocarcinoma in Barrett's esophagus: a new epidemic? Hum Pathol 1992;23:475-6.
3. Pera M, Cameron AJ, Trastek VF, Carpenter HA, Zinsmeister AR. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993; 104:510-3.
4. Hamilton SR. Pathogenesis of columnar cell-lined (Barrett's) esophagus. In: Barrett's oesophagus: pathophysiology, diagnosis and management. Spechler SJ, Goyal RK, editors. New York: Elsevier, 1985;29-37.
5. Naef AP, Savary M, Ozzello L. Columnar-lined lower esophagus: an acquired lesion with malignant predisposition. Report on 140 cases of Barrett's esophagus with 12 adenocarcinomas. J Thorac Cardiovasc Surg 1975;70:826-35.
6. Sjogren RW, Johnson LF. Barrett's esophagus: a review. Am J Med 1983;74:313-20.
7. Skinner DB, Walther BC, Riddell RH, Schmidt H, Lascone C, DeMeester TR. Barrett's esophagus. Comparison of benign and malignant cases. Ann Surg 1983;198:554-66.
8. Haggitt RC, Dean PJ. Adenocarcinoma in Barrett's epithelium. In: Barrett's oesophagus: pathophysiology, diagnosis and management. Spechler SJ, Goyal RK, editors. New York: Elsevier, 1985:153-66.
9. Spechler SJ, Robbins AH, Rubins HB, Vincent ME, Heeren T, Doos WG, et al. Adenocarcinoma and Barrett's esophagus: an overrated risk? Gastroenterology 1984;87:927-33.
10. Cameron AJ, Ott BJ, Payne WS. The incidence of adenocarcinoma in columnar-lined (Barrett's) esophagus. N Engl J Med 1985;313:857-9.
11. Chejfec G, Schnell T, Sontag S. Barrett's esophagus: a preneoplastic disorder. Am J Clin Pathol 1992;98:5-7.
12. Zhuang Z, Vortmeyer AO, Mark EJ, Odze R, Emmert-Buck MR, Merino MJ, et al. Barrett's esophagus: metaplastic cells with loss of heterozygosity at the APC gene locus are clonal precursors to invasive adenocarcinoma. Cancer Res 1996;56: 1961-5.
13. Van der Veen AH, Dees J, Blankenteijn M. Adenocarcinoma in Barrett's esophagus: an overrated risk. Gut 1989;30:14-8.
14. Herbst JJ, Berenson MM, McCloskey DW, Wiser WC. Cell proliferation in esophageal columnar epithelium (Barrett's esophagus). Gastroenterology 1978;75:683-7.
15. Koga Y, Kuwano H, Sugimachi K. Biological characteristics of esophageal epithelial dysplasia assessed by proliferating cell nuclear antigen. Cancer 1996;77:237-44.
16. Jankowski J, McMenemin R, Yu C, Hopwood D, Wormsley KG. Proliferating cell nuclear antigen in oesophageal diseases; correlation with transforming growth factor alpha expression. Gut 1992;33:587-91.
17. Gillen P, McDermott M, Grehan D, Hourihave DO'B, Hennessy TPJ. Proliferating cell nuclear antigen in the assessment of Barrett's mucosa. Br J Surg 1994;81:1766-8.
18. Gray MR, Hall PA, Nash J, Ansari B, Lane DP, Kingsnorth AN. Epithelial proliferation in Barrett's esophagus by proliferating cell nuclear antigen immunolocalization. Gastroenterology 1992;103:1769-76.
19. Hong MK, Laskin WB, Herman BE, Johnston MH, Vargo JJ, Steinberg SM, et al. Expansion of the Ki-67 proliferative compartment correlates with degree of dysplasia in Barrett's esophagus. Cancer 1995;75:423-9.
20. Jankowski J, McMenemin R, Hopwood D, Penston J, Wormsley KG. Abnormal expression of growth regulatory factors in Barrett's oesophagus. Clin Sci 1991;81:663-8.
21. Reid BJ, Sanchez CA, Blount PL, Levine DS. Barrett's esophagus: cell cycle abnormalities in advancing stages of neoplastic progression. Gastroenterology 1993;105:119-29.
22. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Can 1997;33:787-91.
23. Taylor RS, Ramirez RD, Ogoshi M, Chaffins M, Piatyszek MA, Shay JW. Detection of telomerase activity in malignant and non-malignant skin conditions. J Invest Dermatol 1996;106:759-65.
24. Hiyama E, Hiyama K, Tatsumoto N, Kodama T, Shay JW, Yokoyama T. Telomerase activity in human intestine. Int J Oncol 1996;9:1-6.
25. Yashima K, Piatyszek MA, Saboorian MH, Virmani AK, Brown D, Shay JW, et al. Telomerase activity and telomerase in situ telomerase RNA expression in malignant and non-malignant lymph nodes. J Clin Pathol 1997;50:110-7.
26. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol 1997;50:106-9.
27. Ueda M, Koyanagi H, Takeuchi H, Ando N, Kitajima M. Telomerase activity and abnormal expression of p16 and cyclin D1 in Barrett's esophagus. Gastroenterology 1997;112: A635.
28. Yashima K, Litzky LA, Kaiser L, Rogers T, Lam S, Wistuba II, et al. Telomerase expression in respiratory epithelium during the multistage pathogenesis of lung carcinomas. Cancer Res 1997;57:2373-7.